# Tranexamic Acid Versus Blood Stopper Treatments in Epistaxis Management

> **NCT06490653** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Ankara Ataturk Sanatorium Training and Research Hospital** · enrollment: 186 (estimated)

## Conditions studied

- Epistaxis Nosebleed

## Interventions

- **DRUG:** Blood Stopper (Ankaferd)

## Key facts

- **NCT ID:** NCT06490653
- **Lead sponsor:** Ankara Ataturk Sanatorium Training and Research Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-10
- **Primary completion:** 2025-10
- **Final completion:** 2025-12
- **Target enrollment:** 186 (ESTIMATED)
- **Last updated:** 2024-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06490653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06490653, "Tranexamic Acid Versus Blood Stopper Treatments in Epistaxis Management". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06490653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*